Exhibitor

ARTIDIS AG

Artidis

Product categories: In vitro medical device / Digital platform / Biomarkers

 

ARTIDIS AG has developed first ever nanomechanical biomarker for diagnosing cancer and is applying its technology platform of precise tissue measurement in combination with data analytics (up to 180 clinical parameters per patient) to personalize diagnosis and treatment results. ARTIDIS technology is currently being validated in a blinded clinical study on more than 500 patients at the University Hospital, Basel for breast cancer. End of 2019 ARTIDIS will launch a multi-centre study (Europe, US) to test its platform in a neoadjuvant therapy setting for breast and lung cancer. Also ARTIDIS currently runs a feasibility study with a large pharma for drug development beyond oncology.

 

Contact: Marija Plodinec, marija.plodinec@artidis.com

Industry Sectors

  • Biotech

Participated Fairs

  • BIO International Convention 2019

ARTIDIS AG

Hochbergerstrasse 60C
4057 Basel
Switzerland

www.artidis.com

Recommend us

Premium Partner

Strategic partners

Institutional partner

Official program